Ho-wan W. Ip

Sar, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Caecal bascule as an ultra-rare cause of intestinal obstruction: a case report.

Caecal bascule as an ultra-rare cause of intestinal obstruction: a case report.

Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: January 27, 2026

Mechanism of Initial Favorable Response to Decitabine in TP53-Mutated MDS/AML and Potential Mechanisms of Subsequent Relapse.

Mechanism of Initial Favorable Response to Decitabine in TP53-Mutated MDS/AML and Potential Mechanisms of Subsequent Relapse.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 27, 2024

Long noncoding RNA profiling for prognostication in adult acute myeloid leukaemia: abridged secondary publication.

Long noncoding RNA profiling for prognostication in adult acute myeloid leukaemia: abridged secondary publication.

Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: December 19, 2022

Myeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib: clinicohematologic responses, quality-of-life changes and safety in the real-world setting.

Myeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib: clinicohematologic responses, quality-of-life changes and safety in the real-world setting.

Journal: Hematology (Amsterdam, Netherlands)
Published: June 23, 2020

Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation.

Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation.

Journal: Cancer medicine
Published: October 10, 2019

Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3.

Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3.

Journal: Cancer
Published: May 16, 2019

Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective study.

Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective study.

Journal: Cancer
Published: January 08, 2019

Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis.

Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis.

Journal: Annals of hematology
Published: July 28, 2018

Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study.

Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study.

Journal: Cancer
Published: December 27, 2017

Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia.

Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia.

Journal: Science translational medicine
Published: February 01, 2016

Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasms.

Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasms.

Journal: Journal of clinical pathology
Published: January 14, 2016

FLT3 internal tandem duplication in acute promyelocytic leukemia: central nervous system relapse.

FLT3 internal tandem duplication in acute promyelocytic leukemia: central nervous system relapse.

Journal: Annals of hematology
Published: October 24, 2014
Showing 1-12 of 13

Last Updated: 09/26/2026